We are live on ! Find out more
CCB

Cutter & Co Brokerage Portfolio holdings

AUM $423M
1-Year Est. Return 15.02%
This Fund
S&P 500
This Quarter Est. Return
+11.34%
1 Year Est. Return
+15.02%
3 Year Est. Return
+40.36%
5 Year Est. Return
+171.67%
10 Year Est. Return
+252.8%
AUM
$296M
AUM Growth
+$26.6M
Cap. Flow
+$3.96M
Cap. Flow %
1.34%
Top 10 Hldgs %
41.19%
Holding
240
New
14
Increased
65
Reduced
107
Closed
23

Top Buys

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$10.4M
2
CDRE icon
Cadre Holdings
CDRE
+$2.58M
3
WFC icon
Wells Fargo
WFC
+$635K
4
NFG icon
National Fuel Gas
NFG
+$544K
5
LIN icon
Linde
LIN
+$529K

Top Sells

Rank Stock Value
1
GMAB icon
Genmab
GMAB
+$3.77M
2
TDS icon
Telephone and Data Systems
TDS
+$1.94M
3
UGI icon
UGI
UGI
+$751K
4
IFF icon
International Flavors & Fragrances
IFF
+$736K
5
SR icon
Spire
SR
+$553K

Sector Composition

Rank Sector Weight
1 Financials 17.27%
2 Healthcare 15.41%
3 Energy 12.84%
4 Industrials 9.9%
5 Materials 7.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARLP icon
101
Alliance Resource Partners
ARLP
$3.34B
$463K 0.16%
22,800
BATRK icon
102
Atlanta Braves Holdings Series B
BATRK
$3.26B
$462K 0.16%
14,343
LMT icon
103
Lockheed Martin
LMT
$134B
$452K 0.15%
930
UNH icon
104
UnitedHealth
UNH
$376B
$436K 0.15%
823
-15
-2% -$7.95K
IQV icon
105
IQVIA
IQV
$38.7B
$435K 0.15%
2,123
ALPS
106
DELISTED
Alpine Summit Energy Partners
ALPS
$433K 0.15%
86,400
+39,900
+86% +$214K
XOM icon
107
ExxonMobil
XOM
$644B
$428K 0.14%
+3,879
New +$416K
JPM icon
108
JPMorgan Chase
JPM
$935B
$428K 0.14%
3,191
-165
-5% -$20.9K
TMO icon
109
Thermo Fisher Scientific
TMO
$213B
$417K 0.14%
757
+20
+3% +$10.6K
WBD icon
110
Warner Bros
WBD
$65.9B
$415K 0.14%
43,724
-4,610
-10% -$52K
WBA
111
DELISTED
Walgreens Boots Alliance
WBA
$412K 0.14%
11,040
-1,329
-11% -$50K
CSX icon
112
CSX Corp
CSX
$93.4B
$409K 0.14%
13,217
-371
-3% -$11.2K
UDN icon
113
Invesco DB US Dollar Index Bearish Fund
UDN
$109M
$409K 0.14%
22,125
HBAN icon
114
Huntington Bancshares
HBAN
$34.4B
$405K 0.14%
28,718
+6
+0% +$87
COST icon
115
Costco
COST
$422B
$400K 0.14%
875
-176
-17% -$86K
CI icon
116
Cigna
CI
$73.7B
$397K 0.13%
1,197
PVLA
117
Palvella Therapeutics
PVLA
$1.99B
$394K 0.13%
4,731
-351
-7% -$28.2K
INTC icon
118
Intel
INTC
$455B
$393K 0.13%
14,875
+510
+4% +$14.2K
AAAU icon
119
Goldman Sachs Physical Gold ETF Shares
AAAU
$2.46B
$385K 0.13%
21,255
HWKN icon
120
Hawkins
HWKN
$2.67B
$384K 0.13%
9,950
+1
+0% +$41
PM icon
121
Philip Morris
PM
$297B
$384K 0.13%
3,789
-396
-9% -$37.4K
WM icon
122
Waste Management
WM
$90.6B
$378K 0.13%
2,409
+4
+0.2% +$644
LCNB icon
123
LCNB Corp
LCNB
$282M
$373K 0.13%
20,740
FTXR icon
124
First Trust Nasdaq Transportation ETF
FTXR
$1.07B
$369K 0.12%
14,639
+62
+0.4% +$1.61K
SPXU icon
125
ProShares UltraPro Short S&P 500
SPXU
$406M
$367K 0.12%
1,086
+10
+0.9% +$3.47K

Similar funds

Cutter & Co Brokerage's Q4 2022 Portfolio in Review

As of Q4 2022, Cutter & Co Brokerage held 240 positions worth $296M, up 9.9% from $269M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Cutter & Co Brokerage's Q4 2022 filing shows 14 new, 65 increased, 107 reduced and 23 closed positions. Its largest new stake was Wells Fargo: 14,355 shares worth $593K. The largest sale was Genmab, an estimated $3.77M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Energy.

  • Cutter & Co Brokerage's largest Q4 2022 buy was Wells Fargo: 14,355 shares worth $593K.
  • Cutter & Co Brokerage added most to Novo Nordisk in Q4 2022, an estimated $10.4M increase.
  • Cutter & Co Brokerage's biggest Q4 2022 reduction was International Flavors & Fragrances, cutting an estimated $736K.
  • Cutter & Co Brokerage fully exited Genmab in Q4 2022, selling an estimated $3.77M.
  • Cutter & Co Brokerage's ten largest holdings make up 41% of its $296M portfolio in Q4 2022.
  • Cutter & Co Brokerage opened 14 new positions and closed 23 in Q4 2022.
  • Cutter & Co Brokerage's portfolio value rose 9.9% quarter-over-quarter to $296M.

Based on Cutter & Co Brokerage's 13F filing for Q4 2022, filed 3 Feb 2023.